Covid-19: F.D.A. Grants Emergency Authorization for Johnson & Johnson Vaccine
Last Updated
March 25, 2021, 8:31 p.m. ETMarch 25, 2021, 8:31 p.m. ET
Younger American military service members are declining shots. Some colleges and universities, fearing attrition, are pledging to reopen more fully this fall.
Here’s what you need to know:
A doctor receiving the Johnson & Johnson vaccine at a government hospital in Klerksdorp, South Africa, last week.Credit.Shiraaz Mohamed/Associated Press
The Food and Drug Administration on Saturday authorized Johnson & Johnson’s single-shot Covid-19 vaccine for emergency use, beginning the rollout of millions of doses of a third effective vaccine that could reach Americans by early next week.
The Johnson & Johnson campus in Irvine, Calif.Credit.Mark Ralston/Agence France-Presse Getty Images
One day after federal regulators authorized Johnson & Johnson’s Covid-19 vaccine for emergency use, senior Biden administration officials warned Sunday that the supply of the new vaccine would be highly uneven for the next month.
In an effort to lower expectations that the authorization of a third Covid vaccine will mean a steady new stream of doses, the officials said that the company will deliver 3.9 million shots this week but none the week after. The officials were speaking in an organized briefing with reporters but refused to be quoted by name.